Provided by Tiger Trade Technology Pte. Ltd.

Achieve Life Sciences, Inc.

4.09
+0.05001.24%
Volume:313.22K
Turnover:1.27M
Market Cap:217.73M
PE:-3.03
High:4.16
Open:4.04
Low:3.98
Close:4.04
52wk High:6.03
52wk Low:1.84
Shares:53.23M
Float Shares:44.42M
Volume Ratio:0.86
T/O Rate:0.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3500
EPS(LYR):-1.2418
ROE:-161.08%
ROA:-65.45%
PB:6.48
PE(LYR):-3.29

Loading ...

ADVISORY-Alert wrongly tagged to Achieve Life Sciences withdrawn

Reuters
·
Dec 19, 2025

Achieve Closes Its First Debt Settlement Fee Securitization

THOMSON REUTERS
·
Dec 19, 2025

Achieve Life Sciences to Host Meetings During J.P. Morgan Healthcare Conference

Reuters
·
Dec 18, 2025

Achieve Life Sciences Grants Stock Options to New Executives and Employees

Reuters
·
Dec 09, 2025

Achieve Appoints Layla Revis as Senior Vice President of Marketing

THOMSON REUTERS
·
Dec 08, 2025

Achieve Life Sciences Initiated at Market Outperform by Citizens

Dow Jones
·
Nov 25, 2025

Lake Street Keeps Their Buy Rating on Achieve Life Sciences (ACHV)

TIPRANKS
·
Nov 08, 2025

Achieve Life Sciences Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 06, 2025

Achieve Life Sciences Q3 net loss widens

Reuters
·
Nov 06, 2025

Achieve Life Sciences Q3 Operating Expenses USD 14.692 Million

THOMSON REUTERS
·
Nov 06, 2025

Achieve Life Sciences Inc - Pdufa Date for Cytisinicline Set for June 20, 2026

THOMSON REUTERS
·
Nov 06, 2025

Achieve Life Sciences Q3 Net Income USD -14.441 Million VS. Ibes Estimate USD -12.2 Million

THOMSON REUTERS
·
Nov 06, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 06, 2025

Achieve Life Sciences Unveils Cytisinicline Strategy Targeting Nicotine Dependence Market

Reuters
·
Nov 05, 2025

Achieve Life Sciences Inc expected to post a loss of 26 cents a share - Earnings Preview

Reuters
·
Nov 04, 2025

Achieve Life Sciences announces several milestones in its ORCA-OL trial

TIPRANKS
·
Nov 03, 2025

Achieve Life Sciences Inc - Dsmc Finds No Serious Adverse Events in Orca-Ol Trial

THOMSON REUTERS
·
Nov 03, 2025

Achieve Life Sciences Inc: Dsmc Found No Concerns With Respect to Drug Safety

THOMSON REUTERS
·
Nov 03, 2025

Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline Nda for Smoking Cessation

THOMSON REUTERS
·
Nov 03, 2025

Achieve Life Sciences Inc. Files Initial Statement of Beneficial Ownership for Chief Legal Officer Erik Atkisson

Reuters
·
Oct 22, 2025